Suchergebnisse - (Subject:"O3J8G9O825")

PubPharm (5.513)

21

Safety profile of nirmatrelvir-ritonavir : Evidence of adverse events due to drug-drug interactions

enthalten in: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria | 2024

von González-Gómez, �. | Caro-Teller, J. | González-Barrios, I. | +3

22

Paxlovid use is associated with lower risk of cardiovascular diseases in COVID-19 patients with autoimmune rheumatic diseases : a retrospective cohort study

enthalten in: BMC medicine | 2024

von Wang, W. | Wang, Y. | Huang, C. | +3

23

Translated article] Safety profile of nirmatrelvir-ritonavir : Evidence of adverse events due to DDIs

enthalten in: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria | 2024

von González-Gómez, �. | Caro-Teller, J. | González-Barrios, I. | +3

24

Nirmatrelvir and ritonavir

enthalten in: Clinical therapeutics | 2024

von Beninger, P.

25

The effects of nirmatrelvir/ritonavir on tacrolimus levels in lung transplant recipients : A single-center study

enthalten in: Pulmonary pharmacology & therapeutics | 2024

von Wang, X. | Du, W. | Zhang, D. | +2

26

Effectiveness and safety of nirmatrelvir-ritonavir in kidney transplant recipients with severe kidney dysfunction infected with COVID-19

enthalten in: Antimicrobial agents and chemotherapy | 2024

von Yang, H. | Yu, X. | Hou, W. | +8

27

COVID-19 Rebound After VV116 vs Nirmatrelvir-Ritonavir Treatment : A Randomized Clinical Trial

enthalten in: JAMA network open | 2024

von Yang, Z. | Xu, Y. | Zheng, R. | +28

28

Nirmatrelvir/ritonavir for COVID-19 : an overview of systematic reviews

enthalten in: The Journal of antimicrobial chemotherapy | 2024

von Cruciani, M. | Pati, I. | Masiello, F. | +2

29

Evaluation of physicians prescribing of COVID-19 guideline-directed outpatient treatments in a primary care walk-in clinic

enthalten in: Journal of the American Pharmacists Association : JAPhA | 2024

von Denning, K. | Sheppard, J. | Carico, R.

30

Safety and Pharmacokinetics of Lopinavir/Ritonavir Oral Solution in Preterm and Term Infants Starting Before 3 Months of Age

enthalten in: The Pediatric infectious disease journal | 2024

von Bekker, A. | Yang, J. | Wang, J. | +11